Page last updated: 2024-08-22

zalcitabine and Peripheral Nerve Diseases

zalcitabine has been researched along with Peripheral Nerve Diseases in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (5.71)	18.7374
1990's	17 (48.57)	18.2507
2000's	9 (25.71)	29.6817
2010's	6 (17.14)	24.3611
2020's	1 (2.86)	2.80

Authors

Authors	Studies
Galeotti, N; Herdegen, T; Manassero, G; Sanna, MD; Vercelli, A	1
Galeotti, N; Ghelardini, C; Quattrone, A; Sanna, MD	1
Galeotti, N; Ghelardini, C; Mello, T; Quattrone, A; Sanna, MD	1
Galeotti, N; Ghelardini, C; Peroni, D; Quattrone, A; Sanna, MD	1
Garcia-Perez, E; Serra, J; Solà, R; Sumalla, M	1
Blackbeard, J; Dickenson, AH; Hasnie, FS; Hosseini, R; Jina, N; Maratou, K; McMahon, SB; Okuse, K; Orengo, C; Pheby, T; Rice, AS; Wallace, VC	1
Ferrari, LF; Levine, JD	1
Blackbeard, J; Field, MJ; Hasnie, F; O'Dea, KP; Pheby, T; Rice, AS; Segerdahl, A; Takata, M; Wallace, VC	1
Mukai, E	1
Joseph, EK; Levine, JD	1
Chen, X; Levine, JD	1
Blackbeard, J; Hasnie, F; McMahon, SB; Pheby, T; Rice, AS; Segerdahl, AR; Wallace, VC	1
Bernard, R; Bourgoin, S; Brisorgueil, MJ; Conrath, M; Fischer, J; Gingrich, JA; Hamon, M; Van Steenwinckel, J; Vergé, D	1
Arenas-Pinto, A; Bhaskaran, K; Dunn, D; Weller, IV	1
Clifford, DB; Fichtenbaum, CJ; Powderly, WG	1
Simpson, DM; Tagliati, M	1
Cupler, EJ; Dalakas, MC	1
Antoniskis, D; Arezzo, J; Bigley, J; Bozzette, SA; Fischl, MA; Gelb, LD; Gocke, DJ; Grieco, MH; Hirsch, MS; Hyslop, NE; Leedom, JM; Lim, L; LoFaro, ML; McKinley, GF; Merigan, TC; Murphy, RL; Pettinelli, CB; Pottage, JC; Powderly, WG; Ray, G; Reed, N; Richman, DD; Schaumburg, HH; Simon, G; Skowron, G; Soo, W; Spector, SA; Sperber, SJ; Uttamchandani, RB; Zachary, J	1
Hobbs, GA; Keilbaugh, SA; Simpson, MV	1
Arezzo, JC; Berger, AR; Bozzette, S; Merigan, T; Richman, D; Schaumburg, HH; Skowron, G; Soo, W	1
French, MA; Martinez, OP	1
Boswell, W; Buckley, J; Espina, B; Gill, PS; Levine, AM; Nathwani, B; Parker, J; Rasheed, S; Stain, S; Tulpule, A	1
De Simone, C; Famularo, G; Longo, A; Marcellini, S; Moretti, S; Santini, G; Trinchieri, V; Tzantzoglou, S	1
Moyle, GJ; Sadler, M	1
Cross, A; Dunkle, L; Kelleher, T	1
Carey, P	1
Conant, M	1
Dalakas, MC; Leon-Monzon, M; Semino-Mora, C	1
Anderson, TD; Arceo, R; Arezzo, J; Brosnan, C; Davidovich, A; Schaumburg, H	1
Anderson, TD; Brosnan, C; Feldman, D	1
Keilbaugh, SA; Prusoff, WH; Simpson, MV	1
LeLacheur, SF; Simon, GL	1
Broder, S; Dalakas, M; Dubinsky, RM; Yarchoan, R	2

Reviews

5 review(s) available for zalcitabine and Peripheral Nerve Diseases

Article	Year
[Neuromuscular diseases associated with HIV-1 infection]. No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:4 Topics: Anti-HIV Agents; Cytomegalovirus Infections; HIV Infections; Humans; Neuritis; Neuromuscular Diseases; Peripheral Nervous System Diseases; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Zalcitabine; Zidovudine	2004
Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Jun-01, Volume: 9, Issue:2 Topics: Animals; Didanosine; Dideoxynucleosides; Disease Models, Animal; HIV Infections; Humans; Peripheral Nervous System Diseases; Stavudine; Zalcitabine	1995
Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management. Drug safety, 1998, Volume: 19, Issue:6 Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine; Zidovudine	1998
Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine. Clinical therapeutics, 1999, Volume: 21, Issue:7 Topics: Adolescent; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Data Collection; Didanosine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Polypharmacy; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Zalcitabine; Zidovudine	1999
Peripheral neuropathy: zalcitabine reassessed. International journal of STD & AIDS, 2000, Volume: 11, Issue:7 Topics: Anti-HIV Agents; HIV Infections; Humans; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Risk Factors; Zalcitabine	2000

Trials

5 trial(s) available for zalcitabine and Peripheral Nerve Diseases

Article	Year
The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial. Antiviral therapy, 2008, Volume: 13, Issue:2 Topics: Adult; Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Zalcitabine; Zidovudine	2008
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. Annals of internal medicine, 1993, Mar-01, Volume: 118, Issue:5 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Drug Therapy, Combination; Female; Hematologic Diseases; HIV Core Protein p24; Humans; Leukocyte Count; Male; Peripheral Nervous System Diseases; Weight Gain; Zalcitabine; Zidovudine	1993
Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels ov Cancer, 1996, Aug-01, Volume: 78, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; HIV Core Protein p24; HIV-1; Humans; Interleukin-6; Leucovorin; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Remission Induction; Vincristine; Zalcitabine	1996
Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS (London, England), 1997, Volume: 11, Issue:2 Topics: Acetylcarnitine; Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Axons; Cross-Sectional Studies; Didanosine; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine	1997
Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine. Clinical therapeutics, 1999, Volume: 21, Issue:7 Topics: Adolescent; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Data Collection; Didanosine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Polypharmacy; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Zalcitabine; Zidovudine	1999

Other Studies

26 other study(ies) available for zalcitabine and Peripheral Nerve Diseases

Article	Year
The isoform-specific functions of the c-Jun N-terminal kinase (JNK) in a mouse model of antiretroviral-induced painful peripheral neuropathy. European journal of pharmacology, 2020, Aug-05, Volume: 880 Topics: Animals; Anti-Retroviral Agents; Disease Models, Animal; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Mice, Knockout; Pain; Peripheral Nervous System Diseases; Zalcitabine	2020
PKC-mediated HuD-GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy. Pharmacological research, 2014, Volume: 81 Topics: Animals; Anti-HIV Agents; Brain; Disease Models, Animal; ELAV Proteins; ELAV-Like Protein 4; GAP-43 Protein; Hyperalgesia; Male; Mice; Pain; Peripheral Nervous System Diseases; Protein Kinase C; Reverse Transcriptase Inhibitors; Zalcitabine	2014
The RNA-binding protein HuD promotes spinal GAP43 overexpression in antiretroviral-induced neuropathy. Experimental neurology, 2014, Volume: 261 Topics: Animals; Anti-Retroviral Agents; Cells, Cultured; Disease Models, Animal; ELAV Proteins; GAP-43 Protein; Gene Expression Regulation; Hyperalgesia; Male; Mice; Neurons; Oligodeoxyribonucleotides, Antisense; Pain; Peripheral Nervous System Diseases; Phosphopyruvate Hydratase; Protein Kinase C; Spinal Cord; Time Factors; Zalcitabine	2014
Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy. Experimental neurology, 2015, Volume: 267 Topics: Analgesics, Non-Narcotic; Animals; Anti-HIV Agents; Apomorphine; Calcium Channel Blockers; Cell Line, Tumor; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; ELAV Proteins; ELAV-Like Protein 4; Exploratory Behavior; Gene Expression Regulation; Hyperalgesia; Male; Mice; Motor Activity; Neuroblastoma; Pain; Pain Threshold; Peripheral Nervous System Diseases; Ryanodine Receptor Calcium Release Channel; Spinal Cord; Zalcitabine	2015
Behavioral and electrophysiological abnormalities in two rat models of antiretroviral drug-induced neuropathy. Pain, 2015, Volume: 156, Issue:9 Topics: Action Potentials; Animals; Anti-HIV Agents; Disease Models, Animal; Male; Nerve Fibers, Unmyelinated; Neural Conduction; Neurophysiology; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Stavudine; Zalcitabine	2015
Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain. European journal of pain (London, England), 2009, Volume: 13, Issue:4 Topics: Animals; Denervation; Disease Models, Animal; Ganglia, Spinal; Gene Expression Regulation; HIV Envelope Protein gp120; HIV Infections; Male; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; RNA, Messenger; Sensory Receptor Cells; Spinal Nerves; Transfection; Zalcitabine	2009
Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms. The European journal of neuroscience, 2010, Volume: 32, Issue:5 Topics: Alcoholic Neuropathy; Animals; Anti-HIV Agents; Disease Models, Animal; Drug Interactions; Electron Transport Chain Complex Proteins; Ethanol; Hyperalgesia; Male; Mitochondria; Oligodeoxyribonucleotides, Antisense; Peripheral Nervous System Diseases; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; Zalcitabine	2010
The correlation between pain-related behaviour and spinal microgliosis in four distinct models of peripheral neuropathy. European journal of pain (London, England), 2012, Volume: 16, Issue:10 Topics: Animals; Anti-HIV Agents; Behavior, Animal; Disease Models, Animal; Flow Cytometry; Gliosis; Herpes Zoster; Herpesvirus 3, Human; HIV Envelope Protein gp120; HIV Infections; Hyperalgesia; Immunohistochemistry; Male; Microglia; Peripheral Nerve Injuries; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Spinal Cord; Spinal Nerves; Zalcitabine	2012
Caspase signalling in neuropathic and inflammatory pain in the rat. The European journal of neuroscience, 2004, Volume: 20, Issue:11 Topics: Animals; Caspase Inhibitors; Caspases; Ceramides; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Epinephrine; Hyperalgesia; Male; Neuralgia; Neurogenic Inflammation; Neuroprotective Agents; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Signal Transduction; Streptozocin; Time Factors; Tumor Necrosis Factor-alpha; Vincristine; Zalcitabine	2004
Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat. Molecular pain, 2007, Feb-23, Volume: 3 Topics: Acquired Immunodeficiency Syndrome; Alcoholic Neuropathy; Animals; Comorbidity; Disease Models, Animal; Ethanol; Mechanics; Mechanotransduction, Cellular; Nerve Fibers, Unmyelinated; Pain; Peripheral Nervous System Diseases; Rats; Zalcitabine	2007
Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain : a journal of neurology, 2007, Volume: 130, Issue:Pt 10 Topics: Animals; Anti-Bacterial Agents; Anti-HIV Agents; Chemokine CCL2; Cold Temperature; Disease Models, Animal; Epidermis; Ganglia, Spinal; Gliosis; HIV Envelope Protein gp120; Hot Temperature; Hyperalgesia; Male; Minocycline; Motor Activity; Nerve Fibers; Nerve Tissue Proteins; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Zalcitabine	2007
Role of spinal serotonin 5-HT2A receptor in 2',3'-dideoxycytidine-induced neuropathic pain in the rat and the mouse. Pain, 2008, Volume: 137, Issue:1 Topics: Animals; Ganglia, Spinal; Male; Mice; Mice, Knockout; Neuralgia; Nociceptors; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Species Specificity; Spinal Cord; Zalcitabine	2008
Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Oct-01, Volume: 10, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies; Risk Factors; Zalcitabine	1995
Exacerbation of peripheral neuropathy by lamivudine. Lancet (London, England), 1995, Feb-18, Volume: 345, Issue:8947 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Humans; Lamivudine; Male; Peripheral Nervous System Diseases; Zalcitabine	1995
Anti-human immunodeficiency virus type 1 therapy and peripheral neuropathy: prevention of 2',3'-dideoxycytidine toxicity in PC12 cells, a neuronal model, by uridine and pyruvate. Molecular pharmacology, 1993, Volume: 44, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Animals; Cell Survival; DNA Replication; DNA, Mitochondrial; HIV-1; Models, Biological; Neurons; PC12 Cells; Peripheral Nervous System Diseases; Pyruvates; Pyruvic Acid; Uridine; Zalcitabine	1993
2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology, 1993, Volume: 43, Issue:2 Topics: HIV Infections; Humans; Peripheral Nervous System Diseases; Time Factors; Zalcitabine	1993
Acoustic neuropathy associated with zalcitabine-induced peripheral neuropathy. AIDS (London, England), 1993, Volume: 7, Issue:6 Topics: AIDS-Related Complex; Hearing Loss, Sensorineural; Humans; Hypesthesia; Male; Middle Aged; Peripheral Nervous System Diseases; Tinnitus; Vestibulocochlear Nerve Diseases; Zalcitabine	1993
[Zalcitabine]. Enfermedades infecciosas y microbiologia clinica, 1997, Volume: 15, Issue:3 Topics: Adult; Anti-HIV Agents; Digestive System Diseases; Drug Synergism; HIV; HIV Infections; Humans; Peripheral Nervous System Diseases; Retroviridae; Reverse Transcriptase Inhibitors; Zalcitabine	1997
New antiretroviral strategies: interview with Marcus Conant, M.D. Interview by John S. James. AIDS treatment news, 1995, Aug-04, Issue:no 228 Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Therapy, Combination; HIV; HIV Infections; Humans; Isoquinolines; Lamivudine; Peripheral Nervous System Diseases; Protease Inhibitors; Quinolines; Saquinavir; Stavudine; Zalcitabine; Zidovudine	1995
Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC). Laboratory investigation; a journal of technical methods and pathology, 2001, Volume: 81, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; DNA, Mitochondrial; Humans; Microscopy, Electron; Middle Aged; Mitochondria; Peripheral Nervous System Diseases; Schwann Cells; Sural Nerve; Zalcitabine	2001
Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity. Laboratory investigation; a journal of technical methods and pathology, 1992, Volume: 66, Issue:1 Topics: Administration, Oral; Animals; Axons; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophysiology; Female; Male; Myelin Sheath; Neural Conduction; Paresis; Peripheral Nerves; Peripheral Nervous System Diseases; Rabbits; Sciatic Nerve; Zalcitabine	1992
Ultrastructure of peripheral neuropathy induced in rabbits by 2',3'-dideoxycytidine. Laboratory investigation; a journal of technical methods and pathology, 1992, Volume: 66, Issue:1 Topics: Animals; Axons; Dose-Response Relationship, Drug; Edema; Microscopy, Electron; Myelin Proteins; Myelin Sheath; Peripheral Nerves; Peripheral Nervous System Diseases; Rabbits; Schwann Cells; Zalcitabine	1992
The PC12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs. Biochemical pharmacology, 1991, Jun-21, Volume: 42, Issue:1 Topics: Animals; Axons; Bone Marrow; Cell Division; Cell Line, Transformed; Didanosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Peripheral Nervous System Diseases; Stavudine; Tumor Cells, Cultured; Zalcitabine; Zidovudine	1991
Exacerbation of dideoxycytidine-induced neuropathy with dideoxyinosine. Journal of acquired immune deficiency syndromes, 1991, Volume: 4, Issue:5 Topics: Adult; AIDS-Associated Nephropathy; Antiviral Agents; Didanosine; Drug Synergism; Drug Therapy, Combination; HIV Infections; Humans; Male; Peripheral Nervous System Diseases; Zalcitabine	1991
Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC). Muscle & nerve, 1989, Volume: 12, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Axons; Dose-Response Relationship, Drug; Electromyography; Humans; Pain; Peripheral Nervous System Diseases; Zalcitabine	1989
Follow-up of neuropathy from 2',3'-dideoxycytidine. Lancet (London, England), 1988, Apr-09, Volume: 1, Issue:8589 Topics: Deoxycytidine; Drug Administration Schedule; Follow-Up Studies; Humans; Peripheral Nervous System Diseases; Zalcitabine	1988